osteoporosis semaglutide Weight loss induced bone loss: mechanism of action and clinical implications Do GLP-1 Drugs Cause Bone

Body Works regularly works with patients in this range and builds plans around nutrition guidance, metabolic support, and other treatments that move you toward the same goal

The increase in risk was small approximately three to four additional cases per 10,000 patients treated with GLP-1s over 18 months, but clinicians and patients should be aware of this potential association. Researchers said while the risk is low, the rising use of GLP-1s in patients with and without Type 2 diabetes warrants special attention to medication safety

The trial randomised participants to subcutaneous retatrutide at doses of 1 mg, 4 mg, 8 mg and 12 mg or placebo, administered once weekly for a total of 48 weeks

"Using this drug to maintain a body weight that is low for one's frame is not the intended purpose and is most likely a dangerous and unsustainable use of the medication," he warns

I had mobility issues, so I struggled to lose weight myself, but the jab helped me lose seven and a half stone